PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Interim Report
Interim Report 1 2025/26
The first quarter of the fiscal year marks a pivotal moment for PHI as we continue to build momentum across our strategic pillars. Our commitment to innovation, clinical integration, and global expansion remains steadfast, and the progress made this quarter reflects the dedication and ingenuity of our entire team.
PostNews: Press Release
Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ)
The shareholders of Phase Holographic Imaging PHI AB (publ), reg.no. 556542-7811, are hereby invited to attend the annual general meeting on 16 October 2025 at 3 p.m. at the company´s office at Skiffervägen 48 in Lund.
PostNews: Press Release
PHI provides an update regarding the development progress of the new generation of HoloMonitor®
Phase Holographic Imaging PHI AB (“PHI” or the “Company”), a leading provider of advanced holographic imaging solutions, is pleased to update the market on the development progress of its next-generation of HoloMonitor®, which is scheduled for launch before the end of 2025. With the forthcoming launch of the new generation of HoloMonitor®, the Company will be moving into more clinically focused applications and a new, larger market segment.
PostNews: Press Release
Phase Holographic Imaging Signs New Distributor for Singapore and Malaysia
Phase Holographic Imaging PHI AB (“PHI” or the “Company”), is proud to announce the appointment of a new distributor, Gaia Bioscience Pte Ltd, for Singapore and Malaysia. This strategic partnership marks a significant step in PHI’s expansion into Southeast Asia, strengthening and accelerating its presence in one of the world’s most dynamic life science markets.
PostNews: Interim Report
Interim Report 4 2024/25
This spring has been a dynamic and productive period for PHI, as our team and partners have made significant efforts on multiple fronts. Externally, our collaboration with Altium has focused on expanding our sales processes and networks and enhancing our market presence. Internally, our dedicated team has been advancing our ongoing regenerative medicine projects and refining our HoloMonitor technology.
PostNews: Press Release
Phase Holographic: Proposal to amend the Altium Distribution Agreement
Phase Holographic Imaging PHI AB (“PHI” or the “Company”) announces that the Board of Directors has decided to call for an Extraordinary General Meeting to approve a proposed amendment of the distribution agreement with Altium SA (“Altium”), the Company’s global distributor and main shareholder.
Company News
Here, you see PHI featured in recent news and find previous CEO commentaries.
Biostock inverview with acting CEO: ”We aim to drive innovation that accelerates breakthroughs in regenerative medicine”
With the introduction of the HoloMonitor CellSync, Phase Holographic Imaging (PHI) leaps forward in live cell imaging technology. Currently in the final stages of development, this next-generation imaging system is undergoing pre-production testing at prestigious U.S. institutions – the Huntsman Cancer Institute and the Wake Forest Institute of Regenerative Medicine. Biostock has interviewed the acting CEO, Ivan Jurković, to learn more.
Picture-Perfect Science! HoloMonitor® Images Featured on Cover of Advanced Biology
We are proud to announce that a recent study utilizing HoloMonitor® M4 has been featured on the cover of Advanced Biology, Volume 9, Issue 2 (February 2025). The study, led by Dr. Besa Xhabija and colleagues at the University of Michigan-Dearborn, USA, demonstrates the transformative potential of HoloMonitor, our non-invasive, real-time live cell imaging system, in advancing melanoma research.
BioStock: Studio interview with Anders Månsson and Goran Dubravčić
Recently, PHI welcomed Anders Månsson as its new CEO. In a video interview, Månsson and Chairman of the Board Goran Dubravčić discuss the company’s future strategy and the ongoing rights issue.
BioStock: PHI’s new CEO: “I am excited to lead us forward with new energy”
Anders Månsson was recently appointed CEO of Phase Holographic Imaging. With extensive leadership experience in the international life sciences sector, he aims to expand PHI’s global reach and position the company as a leader in non-invasive cell quality control technologies. BioStock spoke with him about his vision for the future.
